Clinical Trial Update: Aripiprazole Added on for DMDD in Youths With ADHD [NA]

View source ↗

Summary

The completed clinical trial NCT03358277 reports addition of aripiprazole for disruptive mood dysregulation disorder in youths with ADHD. The update confirms th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Disruptive Mood Dysregulation Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Disruptive Mood Dysregulation Disorder | NA | Status: COMPLETED